enVVeno Medical Corporation

enVVeno Medical Corporation

NNASDAQ:NVNO
5.95
USD
-0.22
(-3.65%)
-24.83EPS
7.02MMarket Cap
Mar 04Next Earn

Total Valuation

USD

As of June 30, 2026, enVVeno Medical Corporation carries a market capitalization of 7.02M, placing it among publicly traded companies globally. Its enterprise value stands at -13.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap7.02M
Enterprise Value-13.96M

Important Dates

enVVeno Medical Corporation's next confirmed earnings release is scheduled for March 4, 2027.

Earnings Date3/4/2027

Share Statistics

As of June 30, 2026, enVVeno Medical Corporation has 655,521.00 shares outstanding.

Shares Outstanding655,521.00

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio0.34
P/TBV Ratio0.34
P/FCF Ratio-0.46
P/OCF Ratio-0.46

Financial Position

As of June 30, 2026, enVVeno Medical Corporation maintains a current ratio of 11.70, meaning it holds 11.7x the short-term assets needed to cover near-term liabilities.

Current Ratio11.70
Quick Ratio11.39
Debt / Equity2.44
Debt / EBITDA-0.03

Financial Efficiency

Over the twelve months ended June 30, 2026, enVVeno Medical Corporation posted a negative return on equity (ROE) of -58.53, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -53.09, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 34.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-58.53
Return on Assets (ROA)-53.09
Employee Count34.00

Stock Price Statistics

USD

As of the close on November 16, 2026, enVVeno Medical Corporation's stock has declined approximately 59.56% over the past 52 weeks. The 50-day moving average sits at 8.00, while the 200-day moving average is 10.06.

52-Week Price Change-59.56%
50-Day Moving Average8.00
200-Day Moving Average10.06

Income Statement

USD

Over the twelve months ended June 30, 2026, enVVeno Medical Corporation generated - - in revenue and converted that into -15.72M in net income, yielding earnings per share of -24.83. EBITDA reached -16.36M, while operating income came in at -16.75M.

Operating Income-16.75M
Pretax Income-15.72M
Net Income-15.72M
EBITDA-16.36M
EBIT-16.75M
Earnings Per Share (EPS)-24.83

Balance Sheet

USD

As of June 30, 2026, enVVeno Medical Corporation holds 21.49M in cash and equivalents against 505,000.00 in total debt, resulting in a net debt position of -2.84M. Total book value stands at 20.67M, with working capital of 20.20M providing operational flexibility.

Cash & Cash Equivalents21.49M
Total Debt505,000.00
Net Debt-2.84M
Equity (Book Value)20.67M
Book Value Per Share31.53
Working Capital20.20M

Cash Flow

USD

enVVeno Medical Corporation produced -14.62M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -14.62M - equivalent to -23.09 per share.

Operating Cash Flow-14.62M
Free Cash Flow-14.62M
FCF Per Share-23.09

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -215.59: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

FCF Yield-215.59

Stock Splits

enVVeno Medical Corporation's most recent stock split took place on January 20, 2026 with a 35:1 split ratio.

Last Split Date1/20/2026
Split Ratio35:1

Scores

As of June 30, 2026, enVVeno Medical Corporation has an Altman Z-Score of -10.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-10.30